• Je něco špatně v tomto záznamu ?

Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome

I. Lazúrová, Z. Lazúrová, J. Figurová, S. Ujházi, I. Dravecká, J. Mašlanková, M. Mareková

. 2019 ; 68 (3) : 457-465. [pub] 20190322

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19043774

Polycystic ovary syndrome (PCOS) is commonly associated with a higher cardiometabolic risk. The relationship between steroid hormones and cardiometabolic profile in PCOS has been evaluated, but no single hormonal predictor of this association has been identified to determine. To determine the relationship between steroid hormones and cardiometabolic risk factors in PCOS women. Study included 64 women diagnosed with PCOS. Fasting blood samples were analyzed for biochemical, metabolic parameters and sex steroid hormones. PCOS women with BMI>/-27 had significantly higher serum free testosterone (FT), free androgen index (FAI), estrone (E1) (p=0.014, p=0.02, p=0.01) than those with normal weight. In all subjects E1 positively correlated with BMI (p=0.0067), serum insulin (p=0.0046), HOMA-IR (p=0.0125) and negatively with HDL-cholesterol (p=0.009). FAI positively correlated with serum cholesterol (p=0.0457), triacylglycerols (TAG) (p=0.0001), HOMA-IR (p=0.037), and glycemia (p=0.0001), negatively with HDL-cholesterol (p=0.029). In multiple linear regression model E1 most significantly predicted HOMA-IR, whereas FT/FAI predicted HDL-cholesterol and BMI. We conclude that PCOS women with marked overweight or obesity have higher FT, FAI and E1 as compared with nonobese PCOS subjects. E1 and FT may predict worse cardiometabolic profile in PCOS.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19043774
003      
CZ-PrNML
005      
20200122082334.0
007      
ta
008      
200107s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934062 $2 doi
035    __
$a (PubMed)30904012
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Lazúrová, Ivica $7 xx0074091 $u First Department of Internal Medicine, Medical Faculty of P.J. Šafarik University Košice, Košice, Slovakia
245    10
$a Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome / $c I. Lazúrová, Z. Lazúrová, J. Figurová, S. Ujházi, I. Dravecká, J. Mašlanková, M. Mareková
504    __
$a Literatura
520    9_
$a Polycystic ovary syndrome (PCOS) is commonly associated with a higher cardiometabolic risk. The relationship between steroid hormones and cardiometabolic profile in PCOS has been evaluated, but no single hormonal predictor of this association has been identified to determine. To determine the relationship between steroid hormones and cardiometabolic risk factors in PCOS women. Study included 64 women diagnosed with PCOS. Fasting blood samples were analyzed for biochemical, metabolic parameters and sex steroid hormones. PCOS women with BMI>/-27 had significantly higher serum free testosterone (FT), free androgen index (FAI), estrone (E1) (p=0.014, p=0.02, p=0.01) than those with normal weight. In all subjects E1 positively correlated with BMI (p=0.0067), serum insulin (p=0.0046), HOMA-IR (p=0.0125) and negatively with HDL-cholesterol (p=0.009). FAI positively correlated with serum cholesterol (p=0.0457), triacylglycerols (TAG) (p=0.0001), HOMA-IR (p=0.037), and glycemia (p=0.0001), negatively with HDL-cholesterol (p=0.029). In multiple linear regression model E1 most significantly predicted HOMA-IR, whereas FT/FAI predicted HDL-cholesterol and BMI. We conclude that PCOS women with marked overweight or obesity have higher FT, FAI and E1 as compared with nonobese PCOS subjects. E1 and FT may predict worse cardiometabolic profile in PCOS.
650    _2
$a dospělí $7 D000328
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a krevní glukóza $x metabolismus $7 D001786
650    12
$a index tělesné hmotnosti $7 D015992
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a pohlavní steroidní hormony $x krev $7 D012739
650    _2
$a lidé $7 D006801
650    _2
$a inzulinová rezistence $x fyziologie $7 D007333
650    _2
$a metabolom $x fyziologie $7 D055442
650    _2
$a obezita $x krev $x diagnóza $x epidemiologie $7 D009765
650    _2
$a syndrom polycystických ovarií $x krev $x diagnóza $x epidemiologie $7 D011085
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lazúrová, Zora $7 xx0243698 $u Fourth Department of Internal medicine, L. Pasteur University Hospital, Košice, Slovakia
700    1_
$a Figurová, Jana $7 xx0243688 $u First Department of Internal medicine, Medical Faculty of P. J. Šafarik University, Košice, Slovakia
700    1_
$a Ujházi, Simona. $7 xx0243682 $u First Department of Internal medicine, Medical Faculty of P. J. Šafarik University, Košice, Slovakia
700    1_
$a Dravecká, Ingrid $7 xx0076658 $u First Department of Internal medicine, Medical Faculty of P. J. Šafarik University, Košice, Slovakia
700    1_
$a Mašlanková, Jana $7 xx0243687 $u Department of Biochemistry, Medical Faculty of P. J. Šafarik University, Košice, Slovakia
700    1_
$a Mareková, Mária $7 xx0061264 $u Department of Biochemistry, Medical Faculty of P. J. Šafarik University, Košice, Slovakia
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, č. 3 (2019), s. 457-465
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30904012 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20200107 $b ABA008
991    __
$a 20200122082711 $b ABA008
999    __
$a ok $b bmc $g 1485086 $s 1082441
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 68 $c 3 $d 457-465 $e 20190322 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20200107

Najít záznam

Citační ukazatele

Možnosti archivace